Science Explorer Interactive view Map
Nonprofit · Leicester · United Kingdom

Children's Cancer and Leukaemia Group

cclg.org.ukROR OpenAlex
Research works
48
▲ 220% vs 2013–17
Citations
2.1k
44.3 per fractional work
Top-10% rate
24.0%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: Children's Cancer and Leukaemia Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.45× its world share, 1 worksBiochemistry, Geneti…Engineering: 0.03× its world share, 0 worksEngineeringHealth Professions: 0.72× its world share, 0 worksHealth ProfessionsMedicine: 3.79× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 0.60× its world share, 0 worksEconomics, Econometr…Psychology: 0.28× its world share, 0 worksPsychologySocial Sciences: 0.77× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.

Which keywords describe research at Children's Cancer and Leukaemia Group?

By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Prognosis, Immunotherapy, Diagnosis, Treatment, Rituximab, Chemotherapy and Minimal Residual Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors6▲ 29×9 topics
  2. Prognosis4▲ 25×5 topics
  3. Diagnosis4▲ 7.4×7 topics
  4. Immunotherapy4▲ 12×9 topics
  5. Treatment3▲ 5.4×6 topics
  6. Rituximab3▲ 37×2 topics
  7. Chemotherapy3▲ 8.2×14 topics
  8. Minimal Residual Disease2▲ 78×2 topics
  9. Genetic Alterations2▲ 67×2 topics
  10. Acute Lymphoblastic Leukemia2▲ 123×1 topic
  11. Cancer2▲ 3.2×10 topics
  12. Childhood Cancer2▲ 123×1 topic
  13. Genetic Mutations2▲ 8.6×9 topics
  14. Cardiac Amyloidosis2▲ 216×1 topic
  15. Therapeutic Targets2▲ 18×2 topics
  16. Transthyretin2▲ 216×1 topic
  17. Chronic Lymphocytic Leukemia2▲ 85×1 topic
  18. Genomic Aberrations2▲ 85×1 topic
  19. Staging System2▲ 67×2 topics
  20. Childhood Cancer Survivor Study2▲ 90×1 topic
  21. Pediatric Quality of Life Inventory2▲ 90×1 topic
  22. Therapy2▲ 18×2 topics
  23. ALK2▲ 107×1 topic
  24. Clinical Trials2▲ 5.6×8 topics
  25. Neuroblastoma2▲ 107×1 topic
  26. Biomarkers2▲ 5.2×7 topics
  27. Mutation2▲ 19×2 topics
  28. Gene Expression Profiling1▲ 31×2 topics
  29. Hematopoietic Stem Cells1▲ 29×3 topics
  30. Molecular Profiling1▲ 25×2 topics
  31. Radiotherapy1▲ 7.6×5 topics
  32. Kidney Organoids1▲ 76×1 topic
  33. Nephrogenesis1▲ 76×1 topic
  34. BCR-ABL1▲ 91×1 topic
  35. Bayesian Methods1▲ 41×2 topics
  36. Classification1▲ 7.1×2 topics
  37. Genetic Variants1▲ 11×2 topics
  38. Imatinib1▲ 91×1 topic
  39. PET Imaging1▲ 12×3 topics
  40. Nuclear Receptors1▲ 13×4 topics

Which research topics does Children's Cancer and Leukaemia Group publish most on?

By volume in 2022–2025: Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Amyloidosis: Diagnosis, Treatment, Outcomes and Family Support in Illness.

Acute Lymphoblastic Leukemia research: 1 fractional worksChildhood Cancer Survivors' Quality of Life: 1 fractional worksAmyloidosis: Diagnosis, Treatment, Outcomes: 1 fractional worksFamily Support in Illness: 0 fractional worksParathyroid Disorders and Treatments: 0 fractional worksNeuroblastoma Research a…0Neuroblastoma Research and Treatments: 0 fractional worksAcute Myeloid Leukemia Research: 0 fractional worksSarcoma Diagnosis and Treatment: 0 fractional worksHematological disorders and diagnostics: 0 fractional worksPancreatitis Pathology and Treatment: 0 fractional works
Public Health, Environmental and Occupational HealthPediatrics, Perinatology and Child HealthMolecular BiologySociology and Political Science6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
  2. 2 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 1 works
  3. 3 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 1 works
  4. 4 Family Support in Illness Sociology and Political Science 0 works
  5. 5 Parathyroid Disorders and Treatments Nephrology 0 works
  6. 6 Neuroblastoma Research and Treatments Neurology 0 works
  7. 7 Acute Myeloid Leukemia Research Hematology 0 works
  8. 8 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  9. 9 Hematological disorders and diagnostics Emergency Medicine 0 works
  10. 10 Pancreatitis Pathology and Treatment Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.0%not open56.0%

World: 28% of research is openly available.

with international co-authors34.9%domestic only65.1%

World: 19% is written across borders.

How has Children's Cancer and Leukaemia Group's research output changed?

Output in 2018–2022 was 220% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Leicester

All research institutions in Leicester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.